These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34108743)

  • 21. Semiparametric estimation of structural failure time models in continuous-time processes.
    Yang S; Pieper K; Cools F
    Biometrika; 2020 Mar; 107(1):123-136. PubMed ID: 33162561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating lifetime or episode-of-illness costs under censoring.
    Basu A; Manning WG
    Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment.
    Helms LJ; Melnikow J
    Med Care; 1999 Jul; 37(7):652-61. PubMed ID: 10424636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosing Covariate Balance Across Levels of Right-Censoring Before and After Application of Inverse-Probability-of-Censoring Weights.
    Jackson JW
    Am J Epidemiol; 2019 Dec; 188(12):2213-2221. PubMed ID: 31145432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct estimation for adaptive treatment length policies: Methods and application to evaluating the effect of delayed PEG insertion.
    Lu X; Johnson BA
    Biometrics; 2017 Sep; 73(3):981-989. PubMed ID: 28009454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness.
    Greenland S; Mansournia MA
    Eur J Epidemiol; 2015 Oct; 30(10):1101-10. PubMed ID: 25687168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
    Grabner M; Onukwugha E; Jain R; Mullins CD
    Am J Manag Care; 2011 May; 17(5 Spec No):e151-9. PubMed ID: 21711065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slope estimation for informatively right censored longitudinal data modelling the number of observations using geometric and Poisson distributions: application to renal transplant cohort.
    Jaffa MA; Lipsitz S; Woolson RF
    Stat Methods Med Res; 2015 Dec; 24(6):819-35. PubMed ID: 22143404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adapting machine learning techniques to censored time-to-event health record data: A general-purpose approach using inverse probability of censoring weighting.
    Vock DM; Wolfson J; Bandyopadhyay S; Adomavicius G; Johnson PE; Vazquez-Benitez G; O'Connor PJ
    J Biomed Inform; 2016 Jun; 61():119-31. PubMed ID: 26992568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection bias introduced by informative censoring in studies examining effects of vaccination in infancy.
    López-López JA; Sterne JAC; Higgins JPT
    Int J Epidemiol; 2019 Dec; 48(6):2001-2009. PubMed ID: 31071211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case-cohort studies with interval-censored failure time data.
    Zhou Q; Zhou H; Cai J
    Biometrika; 2017 Mar; 104(1):17-29. PubMed ID: 28943643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulating survival data with predefined censoring rates for proportional hazards models.
    Wan F
    Stat Med; 2017 Feb; 36(5):838-854. PubMed ID: 27873333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cost of Joint Replacement: Comparing Two Approaches to Evaluating Costs of Total Hip and Knee Arthroplasty.
    Palsis JA; Brehmer TS; Pellegrini VD; Drew JM; Sachs BL
    J Bone Joint Surg Am; 2018 Feb; 100(4):326-333. PubMed ID: 29462036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of two methods for estimating the technical costs of external beam radiation therapy.
    Hayman JA; Lash KA; Tao ML; Halman MA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):461-7. PubMed ID: 10802374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored.
    Blackhouse G; Briggs AH; O'Brien BJ
    Med Decis Making; 2002; 22(2):173-7. PubMed ID: 11958499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?
    Latimer NR; White IR; Abrams KR; Siebert U
    Stat Methods Med Res; 2019 Aug; 28(8):2475-2493. PubMed ID: 29940824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISION.
    Bao W; Gaffney M; Pressler ML; Fayyad R; Wisemandle W; Beckerman B; Wolski KE; Nissen SE
    Clin Trials; 2020 Oct; 17(5):535-544. PubMed ID: 32643966
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.